AirXpanders Inc., a company developing technology to address current
unmet needs for patients who require tissue expansion for breast
reconstruction surgery, today announced that it has expanded its
senior management team with new hires to help the company prepare for
a successful launch of AeroForm in early 2013.
"We are honored to attract such exceptionally talented, experienced,
and successful professionals to AirXpanders to complement our growing
leadership team as we prepare for a potential U.S. launch of AeroForm
early next year," says Scott Dodson, President and CEO of AirXpanders.
"Enrollment in the pivotal XPAND study of our AeroForm tissue
expansion device in mastectomy patients going through breast
reconstruction is on track. As the study continues, we are working
diligently to prepare our regulatory submission to the FDA and ensure
that we have the proper quality systems in place for a successful
commercial rollout. These high caliber team members will play a
crucial part in the growth and expansion of our company and will add
to our commitment to quality and excellence."
Naghmeh Nouri has been named Senior Director of Quality and
Regulatory, John Lai joins the company as Director of Finance, and
Tony Morefield joins AirXpanders as Senior Director of Operations.
Nouri joins AirXpanders with 28 years of experience as a scientist and
quality expert. She was previously VP of Quality and Regulatory at
Asante Solutions and VP of Quality and Regulatory at Health Hero
Network where she led all activities for quality and regulatory
implementation, product maintenance, and secured a CE Mark, 510K and
managed a new series of FDA regulations. Nouri holds both an M.S. and
a B.S. from the Rutgers Electrical Engineering Honors Program.
Lai, a seasoned financial services professional, joins AirXpanders
after 14 years of experience in the field of accounting and finance.
Previously, John served as Director of Accounting and Finance Services
for Montgomery Professional Services and is an expert in financial
services for medical device companies. John holds a B.A. in Accounting
from Seattle University.
Morefield has over 15 years of experience in the medical device and
aerospace industry with a focus on transitioning innovative
technologies through late stage development into full scale
manufacturing. He most recently held the position of Senior Director
of Manufacturing and Engineering at Avantis Medical Systems where he
was responsible for ramping operations during the course of clinical
studies and into full commercialization with the eventual transition
into off-shore manufacturing. Morefield holds a B.S. from the
University of Oregon.
is a tissue-expansion company focused on the area of breast cancer
reconstruction. By employing a revolutionary patient-controlled
expander, activated by a wireless remote control, the often painful
process of recovering one's feminine shape after cancer can
potentially be eased with this needle-free technology that is easy to
use and may enable the patient to proceed to a permanent implant much
faster than the current standard-of-care. At this time, AirXpanders'
products are not cleared or approved for sale. AirXpanders is backed
by Vivo Ventures, GBS Venture Partners, Prolog Ventures, Heron Capital
and Shalon Ventures.